Packaging of pharmaceuticals ensures protection of the product from various factors such as sunlight, moisture and other environmental factors. This in turn inhibits microbial growth and consequently extends the shelf life of the drug. Pharmaceutical packaging includes bottles, ampoules, blisters, pouches, vials, prefilled syringes and tubes among others. They exhibit various properties such as leakage avoidance, inhibiting the growth of bacteria and barrier against moisture.
Development of new packaging solutions which provide product protection, quality, patient comfort and compliance, and security needs are expected to increase consumer consumption. This in turn is expected to drive the market for novel pharmaceutical packaging. In addition, increasing global drug counterfeit market and the subsequent development of anti-counterfeiting drug packaging technologies and products is expected to boost the demand for pharmaceutical packaging over the next few years. Furthermore, introduction and implementation of numerous stringent regulations and standards for pharmaceutical packaging by regulatory bodies such as Healthcare Compliance Packaging Council (HCPC), National Quality Forum (NQF) and Food and Drug Administration (FDA) is expected to fuel the growth of the market within the forecast period. However, availability of raw materials and volatility in the price of raw materials is expected to hamper the growth of the market. Moreover, complicated registration procedure of packaging is expected to be a key challenge in the growth of the market.
Growing demand for pharmaceutical packaging from Asia Pacific on account of increased contract manufacturing, ageing population and growth of pharmaceutical industry are expected to open new opportunities for the market. In addition, shift towards nano-enabled packaging to enhance barrier properties against light, moisture, and mechanical forces is expected to open opportunities for the growth of the market over the next few years.
The plastic bottles product segment dominated the pharmaceutical packaging market in 2011 owing to the increased demand in North America and Western Europe. Plastic bottles accounted for over 20% of the market in 2011. However, parental containers are expected to show the fastest growth within the forecast period due introduction of new injected therapies. In addition, the label product segment is expected to show significant growth within the forecast period on account of growing number of regulations.
North America dominated the pharmaceutical packaging market and accounted for over 30% of the market in 2011. The dominance of the North American region in the packaging market is primarily due to the large demand of pharmaceutical packaging in the U.S. and Canada. However, Asia Pacific is expected to show the fastest growth within the forecast period due to increased contract manufacturing activities, ageing population and growth of medical industry. Asia Pacific is expected to account for over 25% of the market by 2018.
The pharmaceutical packaging market was highly fragmented in nature with the top five companies accounting for less than 25% of the market in 2011. Amcor, Becton Dickinson, Gerresheimer AG, MeadWestvaco and Rexam PLC were some of the leading manufacturers present in the market. Amcor was the largest company leading the pharmaceutical packaging market in 2011. Some other prominent manufacturers present in the market include West Pharmaceutical Services, Tear and Tape, 3M, Nypro, Schott, Consort Medical and Ypsomed.
The drastic changes in lifestyles, increasing environmental pollution, poor eating habits, and impaired genetics have led to a wide range of medical conditions that are in constant need of treatment. Owing to these reasons, the pharmaceutical industry is also witnessing stupendous growth in several parts of the world, which is triggering the global pharmaceutical packaging market. Correct pharmaceutical packaging ensures safety of the products, extended shelf life, and prevention of microbial growth or contamination.
According to a research report published by Transparency Market Research, the global and U.S. pharmaceutical packaging market was valued at US$50.07 billion in 2011 and is expected to reach US$73.04 billion by 2018, growing at a moderate CAGR of 5.6% from 2012 to 2018. The report gives a detailed explanation of the factors likely to impact this market in a positive and a negative manner. It further assesses the global and U.S. pharmaceutical packaging market with a SWOT analysis to give the readers an accurate insight into the strengths, weaknesses, opportunities, and threats. The report also uses a Porter’s five forces analysis to determine the threat from new entrants, threat of substitute products, bargaining power of customers and suppliers, and intensity of competitive rivalry.
The report segments the global and U.S. pharmaceutical packaging market on the basis of products and regions. The products in the global and U.S. pharmaceutical packaging market are parenteral containers, plastic bottles, closures, labels, other primary packaging, blister packaging, and others. Geographically, this market is divided into North America, Rest of the World, Europe, and Asia Pacific.
Overview of the Pharmaceutical Packaging Market
The expert industry analysts state that Asia Pacific will hold an important position in sustaining the growth of the global pharmaceutical packaging market. Some of the noteworthy factors contributing to this growth will be the growing pharmaceutical industry in Asia Pacific, increasing contract manufacturing, and the ever-increasing geriatric population in this region. The pharmaceutical packaging market in North America held about 30% of the global pharmaceutical packaging market. This demand was fueled by the growing pharmaceutical markets in the U.S. and Canada.
The global pharmaceutical packaging market will also reap generous monetary benefits with technological advancements such as nano-enabled packaging. This packaging method offers a better shield against light, moisture, and mechanical forces.
The research report states that plastic bottles held a market share of about 20% in 2011. However, in the forecast period, the parenteral containers segment is expected to exhibit a remarkable growth rate due to the development of better injected therapies.
Companies Mentioned in the Report
Some of the key players operating in the global and U.S. pharmaceutical packaging industry are Becton Dickinson, Rexam PLC, Nypro Inc, MeadWestvaco, Gerresheimer AG, and Schott AG. Other important players in the global and U.S. pharmaceutical packaging market Nypro, West Pharmaceutical Services, Consort Medical, Ypsomed, Schott, 3M, and Tear and Tape. The report includes a detailed view on the financial outlook of these companies, their marketing strategies, and their research and development plans for the coming few years.
Pharmaceutical Packaging Market: Product Segment Analysis,
- Plastic Bottles
- Parenteral Containers
- Blister Packaging
- Other Primary Packaging
The report provides a detailed analysis of the market with respect to the following regions:
- North America
- United States
- Asia Pacific
- Rest of the World (RoW)
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments